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Abstract
Mental health services increasingly recognize the benefits of monitoring sleep and activity patterns in youth. Objective, eco-
logical monitoring via research grade actiwatches is valid, but an emerging literature suggests using cheaper, consumer grade 
activity tracking devices. This study aimed to compare the cross-validity of these devices, and their feasibility and usability 
in youth mental health settings. A convenience sample of 13 individuals recruited from youth mental health settings wore a 
consumer grade and research grade activity device for seven consecutive days. The five most frequently reported sleep and 
activity variables extracted directly from each device were compared using paired t tests, mean average percentage errors, and 
magnitude and direction of biases. Ten individuals provided usable recordings of sleep and activity parameters. Compared 
to the actiwatch recordings (criterion values), the consumer grade device showed systematic biases in the recording of total 
sleep time (overestimated by about an hour) and waking after sleep onset (underestimated by about half an hour). The con-
sumer grade device was most reliable for monitoring daytime sedentary behaviour. However, participant feedback indicated 
that youth preferred the consumer grade device. The findings suggest that it is inappropriate to substitute actiwatches with 
commercial activity trackers in research setting, as the latter are probably insufficient for precision diagnostics or stratification 
of cases into treatment relevant subgroups. Consumer grade devices are more acceptable to youth, so they may be clinically 
useful for monitoring intra-individual where absolute accuracy is not required.
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Abbreviations
BMI  Body mass index
ConD  Consumer grade sleep-activity tracking device
IQ  Intelligence quotient
IQR  Interquartile range
kg/m2  Kilograms per square metre
MAPE  Mean average percentage error
MVPA  Moderate or vigorous physical activity
ResD  Research grade actigraphy device
SE  Sleep efficiency
s.d.  Standard deviation
s.d.-diff  Standard deviation of the difference
SPSS  Statistical Package for the Social Sciences
TST  Total sleep time
WASO  Waking after sleep onset
YMH  Youth mental health
Introduction
Actigraphy is established as a valuable tool for research 
into sleep, physical and mental disorders. Actigraphy pro-
vides an ecologically valid assessment of sleep with a mod-
est, but manageable loss of data reliability compared to 
polysomnography [1], and it is an acceptable measure of 
energy expenditure if indirect calorimetry is unfeasible [2]. 
Objective monitoring of both sleep and daytime activities is 
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preferable to self-report as the latter show significantly lower 
levels of reliability. For example, whilst adults self-reported 
that they spent 38% of their time in moderate or vigorous 
physical activity (MVPA), actigraphic recordings revealed 
that they spent only 5% of their time at this intensity [3]. 
Overall, there is growing recognition that actigraphy can be 
applied to real-time monitoring of free-living activities in 
general population and clinical studies [4].
Actigraphy is increasingly employed in research in men-
tal disorders, including in individuals at risk of developing 
mood or bipolar disorders [5–7]. Evidence demonstrates that 
actiwatches have utility in evaluating sleep-wake cycles in 
clinical or natural environments, can be employed prospec-
tively to monitor longitudinal changes in symptoms or the 
evolution of an illness prodrome and might be employed to 
assess response to clinical interventions or patterns of recov-
ery [8, 9]. This has led to suggestions that actiwatches could 
be used more widely in day-to-day practice, especially in 
adolescents and young adult populations where both irregu-
lar sleep patterns and low daytime activity may trigger or 
exacerbate health problems [4, 10]. However, research grade 
actiwatches, with their required device readers and software 
programmes, are relatively expensive. This, plus the fact the 
actiwatches may be lost or not returned to the clinic, may 
prohibit their routine use in youth mental health (YMH) set-
tings. Unsurprisingly, it has been suggested that the rapid 
evolution of technology may offer opportunities to employ 
cheaper, consumer-based monitors in research and clinical 
practice [11].
The use of commercially available fitness tracking devices 
and other wearable technology is a key emerging trend of 
the last decade [11]. This ‘quantified self’ movement has 
been made possible by the development of consumer accept-
able, low-cost, stream-lined alternatives to research grade 
medical devices such as actigraphic watches [12–14]. As 
such, it is now considered the norm for an individual to track 
their daily activity levels and sleep patterns via an on-screen 
display on a small wearable or transportable gadget. These 
devices usually link to a web-based interface that allows 
summary data (e.g. weekly number of steps) to be displayed 
on a smart phone, tablet or computer [13]. However, it is 
unclear whether commercial grade tracking devices could 
or should be used as an alternative to research grade acti-
watches in YMH settings. Critically, using a commercial 
device to record rest-activity patterns and monitor personal 
wellness or lifestyle behaviours is a different proposition 
from monitoring putative clinical markers of mental disor-
ders. This is especially likely to be true if the latter results 
in the individual receiving a clinical diagnosis or a recom-
mendation for treatment. In addition, despite widespread 
adoption of commercial devices by youth populations, there 
is relatively little information on their accuracy in clinical 
settings and there has been limited testing of the validity of 
the various rest-activity outputs against ‘criterion’ measures 
[11, 15, 16].
This study examines the validity, feasibility and accept-
ability of using a consumer grade activity device (ConD) 
as a substitute for a commonly used research grade acti-
graphic device (ResD) in the measurement of the five sleep 
and activity variables that are reported most frequently in 
actigraphy studies in youth (see, e.g. [1, 6]. The specific 
aims were to:
(a) compare seven consecutive days of 24-h recordings 
of sleep-wake cycles and to assess the cross-validity 
of the ConD with the ResD on five metrics associated 
with mental and physical health, namely sleep duration, 
waking after sleep onset, sleep efficiency, minutes spent 
in MVPA and proportion of time sedentary.
(b) determine the device feasibility and usability by assess-
ing study dropout and reviewing participant feedback 
regarding the use of ConD and ResD.
Methods
Ethical approval was granted by the north east branch of the 
National Research and Ethical Committee (NREC) in the 
UK (reference: 12/NE/0325) and the University of Sydney 
Human Research Ethics Committee (HREC: 2015/4961) in 
Australia.
Prior to commencing recruitment to the comparison 
study, a literature review was undertaken to identify the time 
duration required for recordings [17] and the most appropri-
ate wrist-worn ConD, including acceptable battery life and 
inter-device reliability of the chosen ConD [18–23]. (further 
information regarding the device selection process is avail-
able from the corresponding author). This established that 
Fitbit© devices were the most appropriate for the present 
study with good inter-device reliability between different 
models and ease of access to minute-level data if required 
(via a Fitbit application programming interface; Fitabase). 
The reference device (Actiwatch-64; Philips Respironics, 
USA) was selected as it was the actiwatch that had been used 
in youth studies undertaken by these and other researchers.
Adherence to the study protocol, recruitment of partici-
pants and collection of data was overseen at both sites by a 
senior researcher (JS).
Sample
A convenience sample was recruited via clinicians involved 
in clinical and research programmes that undertook acti-
graphic monitoring of sleep and/or activity in youth (e.g. a 
pilot study for a new therapy for individuals at risk of bipolar 
disorders; a study of subjective and objective measures of 
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sleep and mood problems in YMH clinic attendees). Eligi-
bility criteria were as used in previous studies by several 
previous research studies by our research groups (see, e.g. 
[6, 10]).
The inclusion criteria were that the individual was (a) 
aged 16–25 years and (b) willing and able to give writ-
ten informed consent to participate. The exclusion criteria 
were: (1) clinically assessed IQ < 70, evidence of intellec-
tual impairment and/or history of head injury; (2) mental 
disorder secondary to a medical condition; (3) substance 
or alcohol use disorder; (4) elevated risk of suicide or self-
harm; (5) regular use of medications that affect sleep, mela-
tonin secretion, circadian rhythms or alertness; (6) evidence 
of other sleep (e.g. sleep apnoea, narcolepsy), neurological 
(e.g. epilepsy) or primary medical conditions associated 
with sleep-wake dysfunction; (7) recent trans-meridian 
travel (i.e. potential for jet lag) or regular shift work; and 
(8) the presence of mobility problems (i.e. unable to walk 
unaided, etc.).
Sleep and activity metrics
We identified the five most commonly reported markers 
of physical and mental health that were available from the 
ResD and could be extracted from the ConD without any 
additional input from the study participant or any need for 
further calculations (e.g. this excluded sleep onset latency as 
this requires additional information). There were three sleep 
and two activity metrics:
(a) total sleep time (TST) and waking after sleep onset 
(WASO) in minutes; and sleep efficiency (SE; reported 
on a 0–1 value) as extracted from the device recordings.
(b) time spent in physical activities of different intensities 
is reported directly by the ConD and by applying pub-
lished algorithms for the ResD [24, 25]. The selected 
metrics, which are easily interpretable and have estab-
lished positive or negative associations with health [3, 
26], were: MVPA (time spent in active minutes) and 
Sedentary Behaviour (reported as a 0–1 value which 
represents the number of minutes sedentary divided by 
the monitoring time).
Procedure
A researcher gave discussed the study protocol and com-
pleted the consent procedures with the participant, then basic 
demographic and health information was recorded or esti-
mated (e.g. height and weight were used to calculate body 
mass index: BMI). Each participant received instructions 
on how to use the ResD and ConD (as required). Individu-
als who did not own a Fitbit© were provided with the basic 
model and a charger for the duration of the study. Time was 
synchronized on both devices and individuals were asked to 
wear the ConD and ResD concurrently for seven consecutive 
days and nights on their non-dominant wrist (For the ConD, 
participants were reminded to recharge the unit on day 5). 
The ‘normal’ setting was selected for detection of sleep and 
activity on the ConD. For the ResD, the ‘usual’ threshold 
(medium sensitivity) was selected for sleep-wake detection.
At the end of the monitoring, the researchers collected 
data from the ConD for each study parameter using the same 
epochs as the ResD (ConD data were obtained by the partici-
pant downloading reports from the website and giving the 
data to a researcher; by giving the researchers direct access 
to the ConD or raw data from Fitabase; or by returning the 
ConD to a researcher). The participant returned the ResD to 
a researcher who downloaded and extracted recordings for 
each study parameter from the actiwatch. The two sets of 
recordings were combined into a data file and any personal 
identifying information was removed.
Individuals who commenced the monitoring week were 
asked to provide verbal feedback about their views and/or 
preferences for using a ConD or ResD. The four questions 
covered acceptability of wearing each device (in terms of, 
e.g. being seen wearing by their peers); how intrusive it was 
to wear and manage the device; any preference in terms of 
using or interacting with the device; any other personal com-
ments or feedback.
Statistical analyses
All analyses were planned a priori and undertaken using 
SPSS (version 23). In free-living conditions, it is known that 
adolescent sleep-wake patterns with entrainment (weekdays 
with regular scheduled activities) may differ from those with 
reduced or no entrainment (e.g. weekends), so analyses take 
this into account (see below).
Normality of distributions for all measured variables was 
established using the Shapiro–Wilk test and statistical sig-
nificance was set at p < 0.05.
Descriptive statistics were used to characterize the sam-
ple; the ConD and ResD data were then compared using 
three approaches:
1. Paired samples t tests were used to assess systematic 
differences between the recordings obtained from the 
ConD and ResD for five consecutive weekdays/week-
nights.
2. Mean absolute percentage error (MAPE) values were 
then calculated. The MAPE provides an indication of 
the absolute value of the error and is estimated for the 
ConD by dividing the absolute bias (ResD–ConD) by 
the ResD (criterion value) measure and multiplying by 
100 [11, 13].
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3. Bland–Altman (difference) plots were used to determine 
whether the ConD provides an over- or under-estimation 
of any metric compared to the ResD [27]. We plotted 
two points on each Bland–Altman graph for each par-
ticipant (one represents the comparison of weekday 
values and the other the weekend values). To create the 
graph, it is first necessary to compute the mean bias for 
the measure (i.e. the mean difference between the ResD 
and ConD), along with the standard deviation (s.d.) of 
the bias. Next the lower and upper limits of the level of 
agreement are calculated (± 1.96 × s.d. of the bias). The 
mean difference is then plotted against the average of the 
two measures (i.e. ConD plus ResD divided by two). A 
positive bias indicates that the ConD over-estimates the 
ResD values, whilst a negative bias indicates that the 
ConD under-estimates the ResD values.
Power calculation
We used data from our own and other previous studies to 
determine the sample size required for the paired t tests 
(using http://sampl esize calcu lator .com). Assuming a TST 
of 7–8 h and a 10% difference between TST recorded on 
the ConD and ResD (42–48 min) and a predicted s.d. of the 
difference (s.d.-diff) of about 30 min, then 7–8 individuals 
are required to achieve 80% statistical power for identifying 
a statistically significant difference (at p < 0.05). Likewise, 
six participants are required if we assume the SE is 0.8–0.9, 
with a 10% difference in the SE between devices (and a 
s.d.-diff of 0.05). Based on previously reported dropout rates 
from actigraphy (10–35%) and objective monitoring studies 
of youth (20–40%) and to allow for random missing record-
ings of sleep or activity variables, we estimated that if a 
minimum of 12 individuals commenced the study, we would 
obtain the required data from 8 to 10 individuals.
Results
Thirteen individuals commenced data collection, but two did 
not attend the follow-up appointment (and did not provide 
data) and ConD data were unavailable for another individual.
The included sample comprised of 10 youth (6 females) 
with a median age of 19.3 years (interquartile range, IQR 
17–21) and a median BMI of 22.3 kg/m2 (IQR 18.9–25.7). 
All individuals reported depressive symptoms, four also 
reported anxiety symptoms, three reported symptoms of 
hypomania and one had a history of hallucinations. Five 
individuals had a family history of mood disorders (uni-
polar and/or bipolar) and four individuals were currently 
prescribed psychotropic medication. Characteristics of indi-
viduals recruited in England (n = 6) did not differ from those 
recruited in Australia.
All ten individuals provided sleep and activity data for 
five consecutive weekdays, but one individual did not wear 
an actiwatch for the weekend. As shown in the paired t tests 
reported in Table 1, the ConD gives significantly higher 
values for weeknight TST and SE and for weekday MVPA 
compared to the ResD and significantly lower values for 
weeknight WASO and weekday sedentary behaviour. The 
MAPE indicates that the percentage error for measurements 
undertaken by the ConD is particularly high for WASO 
(45%), exceeds 10% for TST and MVPA, but is lower for 
the SE (9%) and Sedentary Behaviour (5%).
As shown in Table 2 and Fig. 1, the above findings trans-
late into a high level of systematic bias for sleep measures, 
with the ConD over-estimating the TST by about one hour 
(+ 56.41 min) and underestimating WASO by about half an 
hour (− 29.65 min) compared to the ResD. In additon, the 
ConD overestimated SE by about seven percent (+ 0.074). 
Daytime activity parameters were less prone to bias (MVPA 
overestimated by about 6 min; Sedentary Behaviour under-
estimated by about 4%) (Fig. 5).
Table 1  Paired t tests for 
five selected health markers 
measured on consecutive 
weekdays using a commercial 
grade (ConD) and research 
grade device (ResD) and 
the estimated mean average 
percentage error of the ConD
Sample size = 10
df degrees of freedom, TST total sleep time, WASO waking after sleep onset; SE: sleep efficiency measured 
as a proportion on 0–1 scale (see text for details), MVPA moderate or vigorous physical activity, Sedentary 
Behaviour is measured as a proportion on 0–1 scale (see text for details), MAPE mean average percentage 
error of the ConD versus ResD (to nearest whole number)
Variable Mean (s.d.) Paired t test MAPE (%)
Consumer device Research device t test (df 9) p
TST in minutes 482.21 (83.91) 425.30 (62.27) 13.52 0.001 13
WASO in minutes 35.98 (20.14) 65.63 (31.49) 5.84 0.001 45
SE 0.886 (0.040) 0.812 (0.055) 8.29 0.001 9
MVPA in minutes 50.51 (38.15) 44.33 (33.28) 2.67 0.026 14
Sedentary behaviour 0.660 (0.166) 0.698 (0.164) 3.44 0.007 5
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Feedback from nine participants suggested that whilst the 
ConD was highly acceptable there was less enthusiasm for 
the ResD. This appeared to focus on two main issues. First, 
whilst no individual refused to wear the ResD, five individu-
als expressed concern that wearing an actiwatch identified 
them as ‘a patient’. Three of these individuals indicated that 
they regarded wearing a medical device as potentially stig-
matising and said they would be reluctant to use an actiwatch 
for an extended period. In addition, six individuals reported 
that they were disappointed that there is no option to review 
the ResD recordings for themselves and that they preferred 
the ConD because it allowed them to examine their daytime 
activity and sleep pattern in real-time using the device dis-
play or web-based interface on their phone or tablet.
Conclusions
Low levels of daytime activity and disrupted sleep patterns 
in youth are not only a public health concern, but also are 
increasingly regarded as important targets for assessment 
and monitoring in YMH settings [28]. This prompted us 
to examine whether a consumer grade rest-activity tracker 
might be used as a substitute for a research grade actigraphic 
device, and in what circumstances it might be employed. 
We discuss in the findings and limitations of the study and 
consider the implications for both research and clinical prac-
tice from the perspective of utility and acceptability of the 
different tools.
Seventy percent (10 of 13) of YMH attendees who con-
sented to participate in this study provided simultaneously 
recorded data from the ResD and ConD. Using ResD outputs 
as the criterion values, the findings indicate that the ConD 
shows only modest levels of accuracy overall (MAPE range 
from 4 to 45%). As in some previous studies, the use of 
ConD for monitoring sleep is undermined by the significant 
overestimation of TST and under-estimation of WASO (and 
the consequence impact on SE estimation) [20, 23, 29, 30]. 
Table 2  Bias and limits of agreement between a commercial grade 
(ConD) and research grade device (ResD) for five selected health 
markers (see plots in Figs. 1, 2, 3, 4)
Bias is estimated as the mean difference for ConD–ResD values (see 
text for details); limits of agreement are estimated as ± 1.96 × s.d. of 
bias
TST total sleep time, WASO waking after sleep onset, SE sleep effi-
ciency measured as a proportion on 0–1 scale (see text for details), 
MVPA moderate or vigorous physical activity; Sedentary Behaviour 
is measured as a proportion on 0–1 scale (see text for details)
Variable Bias Lower and upper 
limits of agreement
TST in minutes + 56.41 − 45.27, + 158.10
WASO in minutes − 29.65 + 3.78, − 63.10
SE + 0.074 + 0.020, + 0.126
MVPA in minutes + 6.17 − 5.68, + 18.03
Sedentary behaviour − 0.038 + 0.042, − 0.118
Fig. 1  Sleep duration in minutes
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Although MVPA is overestimated by the ConD, the daytime 
activity metrics appear to be slightly more representative of 
the ResD values than the sleep metrics [18, 19, 31].
The strength of this study is that metrics and analyses 
were selected a priori and the sample size was calculated 
to allow use of paired t tests, MAPE and bias estimates 
(using Bland–Altman methods). This approach is prefer-
able to correlational analyses as these may conflate appar-
ent agreements between ConD and ResD [32], whilst 
concealing the magnitude of any errors and/or whether 
Fig. 2  Wake after sleep onset 
(WASO) in minutes
Fig. 3  Sleep efficiency
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discrepancies are primarily due to over- or under-esti-
mation of values [33]. However, the current study has 
several limitations. For example, we cannot definitively 
state that other rest-activity metrics extracted from ConD 
or ResD will show the biases reported for the five vari-
ables selected, although the indications in the emerging 
Fig. 4  Minutes spent in moder-
ate or vigorous physical activity 
(MVPA)
Fig. 5  Percentage of time 
sedentary
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literature is that the emerging literature is consistent with 
our findings (and indicates problems with other measures 
such as sleep latency onset) [18–23, 31]. The metrics we 
chose were selected because of their widespread use in 
research and clinical practice, but also because it was 
easy to extract data for the variables and it was possible 
to examine them without recourse to sleep or activity dia-
ries (although the ideal would be to use self-report diaries 
alongside objective data collection, we wished to minimize 
participant burden). Further, we chose an activity tracker 
produced by one manufacturer. Whilst this decision is jus-
tifiable, we cannot simply extrapolate findings from this 
ConD to other devices. The pre-study review indicated that 
the device we chose was the optimal ConD available for 
the study, but this is a rapidly developing field and test-
ing of new ConD or new models of existing devices will 
be necessary. In addition, the 7-day recording period was 
appropriate for comparing the mean values for sleep and 
activity parameters, but a longer duration is required to 
extend analyses to, e.g. the study of variability [34]. This 
may create further issues in collecting data from com-
mercial devices (as batteries need to be recharged every 
5 days). Lastly, the sample size was sufficient for the pri-
mary analyses, but is insufficient to explore potential con-
founders of reported findings or predictors of the biases 
observed.
The data recordings from ConD and ResD are derived 
from accelerometers and the presumption is that wrist 
movements can be used as a proxy for monitoring daytime 
activity patterns, whilst the absence of movement at night 
equates to sleep. We found that the ConD was insuffi-
ciently sensitive to night-time movement; thus, the current 
study suggests ConD are a relatively poor substitute for 
ResD for research targeted specifically at sleep patterns. 
We speculate that this could indicate that, although the 
ConD contains a triaxial accelerometer system, the cali-
bration of the system for the horizontal plane may be less 
accurate (the problem of over-estimating TST and under-
estimating WASO was reversed but not resolved using the 
higher sensitivity setting on the ConD). We emphasize that 
this is a hypothesis that requires testing, but the normal 
setting produced significantly different values for the sleep 
metrics compared to the ResD. In contrast, daytime esti-
mates of MVPA and sedentary behaviour (mostly sitting 
rather than lying down) appeared to be more comparable 
with the actiwatch recordings. However, from a techno-
logical point of view, we do not know for certain if it is 
the hardware or the software that performs less well in 
the ConD (or both). As such, the findings warrant further 
testing in larger studies with, e.g. samples undertaking 
more detailed, systematic clinical assessments; use of self-
report diaries to clarify the nature of rest-activity behav-
iours; comparisons with other gold standard measures; 
using different types of ConD; experimenting with dif-
ferent device sensitivity settings; and longer periods of 
recording.
One of the reasons for increased interest in objective 
measures of sleep and activity cycles is their potential use 
in personalised or precision medicine [35]. At this stage, 
assuming our findings is confirmed by others, we do not 
recommend employing the ConD for personalised diagnos-
tics in youth. For instance, using a ConD is unlikely to help 
to screen for or reliably determine whether an individual is 
experiencing a clinically meaningful delayed sleep phase; 
nor is a ConD likely to provide sufficient information to 
enhance treatment selection. However, ConD might be use-
ful, e.g. to assess within-subject changes in daytime activity 
or sleep patterns in situations where absolute accuracy is 
not required. This application could help in clinical prac-
tice where intra-individual monitoring may help to ascer-
tain whether a specific intervention or treatment (that has 
already been selected) is having a positive effect on activity 
levels or sleep patterns [8, 36]. Further, the availability and 
acceptability of ConD and the opportunity for real-time self-
monitoring may increase their potential utility as an adjunct 
to repeated prospective assessments of clinical progress. In 
youth, their preference for using a ConD may increase the 
likelihood of engagement in monitoring rest-activity pat-
terns and therefore increasing the amount of data available 
to a clinician or researcher. In addition, its use may enhance 
collaboration between clinicians and clients.
In conclusion, an advantage of research grade acti-
watches is that they measure and store much more data and 
the algorithms allow evaluation of many more sleep-wake 
cycle parameters than ConD. A major disadvantage is that 
actiwatch data are not readily available to the wearer and 
youth are ambivalent or against their routine use. However, 
the perceived benefits of ConD in youth may be insufficient 
in situations where reliable data on a sophisticated set of 
parameters, as available from ResD, are critical to the deci-
sion-making process. Thus, the current study suggests that 
ResD is preferable for precision diagnostics or attempts to 
stratify cases into treatment relevant subgroups. For other 
purposes, there may be a need to consider the ‘trade off’ 
between quality of data recording versus the likelihood of 
obtaining the required quantity of sleep and activity data.
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